Welcome to our dedicated page for Adapthealth news (Ticker: AHCO), a resource for investors and traders seeking the latest updates and insights on Adapthealth stock.
AdaptHealth Corp. (NASDAQ: AHCO) is a national provider of patient-centered, healthcare-at-home solutions, and this news page focuses on its latest corporate and financial developments. The company’s public announcements describe a business centered on home medical equipment, medical supplies, and related services, organized into four segments: Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home.
Visitors to this AdaptHealth news feed can review press releases on quarterly earnings, financial guidance, capital structure updates, and ratings actions. Recent communications have included results for the second and third quarters, commentary on net revenue, net income, cash flow from operations, and the use of non-GAAP metrics such as Adjusted EBITDA, free cash flow, and organic revenue, as described by the company.
The news flow also covers strategic and operational updates. AdaptHealth has announced a definitive agreement to serve as the exclusive provider of home medical equipment and supplies for a major national healthcare system under a capitated model, as well as additional capitated agreements with payors. The company has reported dispositions of certain assets in its Wellness at Home segment and highlighted digital patient engagement initiatives through its own tools.
In addition, this page aggregates AdaptHealth’s disclosures about participation in healthcare and finance conferences, earnings release dates, and investor conference calls. For investors and observers tracking AHCO, the news stream provides direct access to the company’s own descriptions of its performance, partnerships, and healthcare-at-home operations across sleep, respiratory, diabetes, and wellness product categories.
AdaptHealth (NASDAQ: AHCO) will participate in two investor conferences in Miami in March 2026: the J.P. Morgan Global Leveraged Finance Conference on March 3, 2026 (fireside chat at 11:00 a.m. ET) and the Leerink Partners Global Healthcare Conference on March 9, 2026 (fireside chat at 2:20 p.m. ET).
Webcasts will be available via the company's Investor Relations website. AdaptHealth serves roughly 4.3 million patients annually through ~640 locations across 48 states in four reportable segments: Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home.
AdaptHealth (NASDAQ: AHCO) reported fourth-quarter and full-year 2025 results and issued 2026 guidance. Full-year net revenue was $3,244.9M (down 0.5%); Adjusted EBITDA was $616.7M (down 10.5%). The company recorded a $128.0M non-cash goodwill impairment and reduced net debt by $250M for 2025.
2026 guidance: net revenue $3.44B–$3.51B, Adjusted EBITDA $680M–$730M, and free cash flow $175M–$225M. Management cited patient census records and operational investments supporting a large capitated contract.
AdaptHealth (NASDAQ: AHCO) will release fourth quarter and full year 2025 financial results before market open on Tuesday, February 24, 2026. Management will host a teleconference at 8:30 a.m. ET for analysts and investors with domestic and international dial-in numbers and Conference ID AHCO4Q25.
A live webcast requires registration and a replay will be available for six months on the company's Investor Relations site at www.adapthealth.com.
AdaptHealth (NASDAQ: AHCO) said Moody’s upgraded its Corporate Family Rating to Ba2 from Ba3 and raised its senior unsecured notes rating to B1 from Ba3. The company cited prior S&P upgrade in November 2025, meaningful reduction in its Term Loan A since Q3 2024 funded by free cash flow and proceeds from non-core asset dispositions, and a focus on debt reduction and financial flexibility. AdaptHealth serves ~4.3 million patients annually through ~640 locations in 47 states across Sleep, Respiratory, Diabetes, and Wellness at Home segments.
AdaptHealth (NASDAQ: AHCO) will participate in the BofA Securities Leveraged Finance Conference in Boca Raton, FL on Tuesday, December 2, 2025, including a fireside chat at 8:10 a.m. ET. A webcast link will be available on the company website under Investor Relations.
AdaptHealth provides healthcare-at-home solutions across four reportable segments: Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home, serving about 4.2 million patients annually through approximately 630 locations in 47 states.
AdaptHealth (NASDAQ: AHCO) said S&P Global Ratings upgraded its issue-level rating on the company’s senior unsecured debt to BB- from B+ and raised its recovery rating to 4 from 5.
S&P attributed the upgrade to $225 million of year-to-date prepayment on the senior secured term loan A due 2029, which S&P said improves recovery prospects for unsecured noteholders. Management noted it reduced term loan A by $275 million since end of Q3 2024 using free cash flow and proceeds from non-core asset dispositions.
AdaptHealth (NASDAQ: AHCO) reported third-quarter 2025 results for the period ended September 30, 2025. Net revenue was $820.3M, up 1.8% year-over-year, with organic revenue +5.1%. Net income was $24.5M versus $22.9M a year earlier and Adjusted EBITDA was $170.1M, up 3.5%. The company reduced debt by $50.0M in the quarter and $225.0M year-to-date, leaving net leverage at 2.68x vs a stated target of 2.50x. Year-to-date operating cash flow was $418.6M and free cash flow was $140.1M (down from $162.7M prior year). Registered myApp users rose to 271,000 from 118,000. Guidance for FY2025 was maintained: Net revenue $3.18B–$3.26B, Adj. EBITDA $642M–$682M, FCF $170M–$190M.
AdaptHealth (NASDAQ: AHCO) will participate in the UBS Global Healthcare Conference in Palm Beach Gardens, FL on Tuesday, November 11, 2025, including a fireside chat at 1:15 p.m. ET. A webcast link will be available on the company’s Investor Relations page at www.adapthealth.com.
AdaptHealth provides home medical equipment, supplies and related services across four reportable segments: Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home. The company serves beneficiaries of Medicare, Medicaid and commercial payors and reached approximately 4.2 million patients annually through about 660 locations in 47 states.
AdaptHealth (NASDAQ: AHCO) will release third quarter 2025 financial results before market open on Tuesday, November 4, 2025. Management will host a teleconference at 8:30 a.m. ET for analysts and investors to discuss results and business activities. Participants may dial (800) 343-4849 (Domestic) or (203) 518-9848 (International) and reference Conference ID: AHCO2Q25.
A webcast requires registration and a replay will be available for six months on the company's Investor Relations site at www.adapthealth.com.
AdaptHealth Corp. (NASDAQ: AHCO), a national leader in healthcare-at-home solutions, will participate in the Jefferies Healthcare Services Conference in Nashville on September 29, 2025. The company will engage in a fireside chat at 11:30 a.m. CST, with the webcast available on their website.
AdaptHealth operates across four segments: Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home, serving approximately 4.2 million patients annually through 630 locations in 47 states. The company partners with various healthcare providers and serves Medicare, Medicaid, and commercial insurance beneficiaries.